메뉴 건너뛰기




Volumn 16, Issue 4, 2013, Pages 575-579

Cost-effectiveness of TAVR in the non-surgical population

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; CARDIAC PATIENT; CLINICAL PRACTICE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; LEARNING CURVE; LIFE EXPECTANCY; POSTOPERATIVE COMPLICATION; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; REIMBURSEMENT; REVIEW; SURGICAL MORTALITY; SURGICAL RISK; TOTAL QUALITY MANAGEMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION;

EID: 84875710503     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2013.772753     Document Type: Review
Times cited : (5)

References (27)
  • 1
    • 35748960837 scopus 로고    scopus 로고
    • Unoperated patients with severe aortic stenosis
    • Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol 2007;50:2018-9
    • (2007) J Am Coll Cardiol , vol.50 , pp. 2018-2019
    • Bach, D.S.1    Cimino, N.2    Deeb, G.M.3
  • 2
    • 80255137247 scopus 로고    scopus 로고
    • Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: The U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry
    • Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58:2130-8
    • (2011) J Am Coll Cardiol , vol.58 , pp. 2130-2138
    • Moat, N.E.1    Ludman, P.2    De Belder, M.A.3
  • 3
    • 77649212932 scopus 로고    scopus 로고
    • Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: Acute and late outcomes of the multicenter Canadian experience
    • Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-90
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1080-1090
    • Rodes-Cabau, J.1    Webb, J.G.2    Cheung, A.3
  • 4
    • 34547919242 scopus 로고    scopus 로고
    • Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis
    • Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-63
    • (2007) Circulation , vol.116 , pp. 755-763
    • Webb, J.G.1    Pasupati, S.2    Humphries, K.3
  • 5
    • 77958594295 scopus 로고    scopus 로고
    • Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery
    • Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607
    • (2010) N Engl J Med , vol.363 , pp. 1597-1607
    • Leon, M.B.1    Smith, C.R.2    MacK, M.3
  • 6
    • 84860494889 scopus 로고    scopus 로고
    • Transcatheter aortic-valve replacement for inoperable severe aortic stenosis
    • Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366: 1696-704
    • (2012) N Engl J Med , vol.366 , pp. 1696-1704
    • Makkar, R.R.1    Fontana, G.P.2    Jilaihawi, H.3
  • 7
    • 84875731422 scopus 로고    scopus 로고
    • Transfemoral aortic valve replacement versus medical management in high risk patients with symptomatic aortic valve stenosis: Canadian cost-effectiveness analysis based on the PARTNER trial cohort B findings
    • (in press)
    • Hancock-Howard R, Feindel C, Rodes-Cabau J, et al. Transfemoral aortic valve replacement versus medical management in high risk patients with symptomatic aortic valve stenosis: Canadian cost-effectiveness analysis based on the PARTNER trial cohort B findings. J Med Econ (in press)
    • J Med Econ
    • Hancock-Howard, R.1    Feindel, C.2    Rodes-Cabau, J.3
  • 8
    • 84875753236 scopus 로고    scopus 로고
    • TAVI: Reveal the truth, the whole truth and nothing but the truth
    • (in press)
    • Neyt M, Van Brabandt H. TAVI: reveal the truth, the whole truth and nothing but the truth. J Med Econ (in press)
    • J Med Econ
    • Neyt, M.1    Van Brabandt, H.2
  • 9
    • 84879171204 scopus 로고    scopus 로고
    • Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: A Canadian perspective
    • doi:10.1016/j.jtcvs.2012.06.018. (Published online 16 July 2012.)
    • Doble B, Blackhouse G, Goeree R, et al. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. J Thorac Cardiovasc Surg 2012; doi:10.1016/j.jtcvs.2012. 06.018. (Published online 16 July 2012.)
    • (2012) J Thorac Cardiovasc Surg
    • Doble, B.1    Blackhouse, G.2    Goeree, R.3
  • 10
    • 84859796494 scopus 로고    scopus 로고
    • Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients
    • Gada H, Kapadia SR, Tuzcu EM, et al. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol 2012;109: 1326-33
    • (2012) Am J Cardiol , vol.109 , pp. 1326-1333
    • Gada, H.1    Kapadia, S.R.2    Tuzcu, E.M.3
  • 11
    • 84862210249 scopus 로고    scopus 로고
    • A cost-utility analysis of transcatheter aortic valve implantation in Belgium: Focusing on a well-defined and identifiable population
    • doi:10.1136/bmjopen-2012-001032
    • Neyt M, Van Brabandt H, Devriese S, et al. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2012;2. doi:10.1136/bmjopen-2012-001032.
    • (2012) BMJ Open , vol.2
    • Neyt, M.1    Van Brabandt, H.2    Devriese, S.3
  • 12
    • 84863230665 scopus 로고    scopus 로고
    • Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: Results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B)
    • Reynolds MR, Magnuson EA, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation 2012;125: 1102-9
    • (2012) Circulation , vol.125 , pp. 1102-1109
    • Reynolds, M.R.1    Magnuson, E.A.2    Wang, K.3
  • 13
    • 84857113470 scopus 로고    scopus 로고
    • Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement
    • Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2012;98:370-6
    • (2012) Heart , vol.98 , pp. 370-376
    • Watt, M.1    Mealing, S.2    Eaton, J.3
  • 14
    • 84857884549 scopus 로고    scopus 로고
    • Cost-effectiveness of transcatheter aortic valve replacement
    • Hlatky MA, Simons CT. Cost-effectiveness of transcatheter aortic valve replacement. Circulation 2012;125:1076-7
    • (2012) Circulation , vol.125 , pp. 1076-1077
    • Hlatky, M.A.1    Simons, C.T.2
  • 15
    • 80255135508 scopus 로고    scopus 로고
    • Health related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis
    • Reynolds MR, Magnuson EA, Lei Y, et al. Health related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 2011;124:1964-72
    • (2011) Circulation , vol.124 , pp. 1964-1972
    • Reynolds, M.R.1    Magnuson, E.A.2    Lei, Y.3
  • 16
    • 84862011904 scopus 로고    scopus 로고
    • Cost-effectiveness of transcatheter aortic valve replacement: Overoptimistic study results and a call for publication of complete trial results
    • Neyt M, Van Brabandt H. Cost-effectiveness of transcatheter aortic valve replacement: overoptimistic study results and a call for publication of complete trial results. Heart 2012;98:1031-3
    • (2012) Heart , vol.98 , pp. 1031-1033
    • Neyt, M.1    Van Brabandt, H.2
  • 17
    • 84864530669 scopus 로고    scopus 로고
    • Transcatheter aortic valve implantation (TAVI): Risky and costly
    • Van Brabandt H, Neyt M, Hulstaert F. Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ 2012;345:e4710
    • (2012) BMJ , vol.345
    • Van Brabandt, H.1    Neyt, M.2    Hulstaert, F.3
  • 18
    • 84875747994 scopus 로고    scopus 로고
    • The Edwards SAPIEN THV Transcatheter Heart Valve System for patients with severe aortic stenosis who are not candidates for conventional open-heart aortic valve replacement surgery
    • U.S. Food and Drug Administration Accessed October 25, 2012
    • U.S. Food and Drug Administration. The Edwards SAPIEN-THV Transcatheter Heart Valve System for patients with severe aortic stenosis who are not candidates for conventional open-heart aortic valve replacement surgery. Briefing document for the Circulatory Systems Device Panel Advisory Committee. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeeting Materials/MedicalDevices/MedicalDevicesAdvisoryCommittee/Circulatory SystemDevicesPanel/UCM262935.pdf. Accessed October 25, 2012
    • Briefing Document for the Circulatory Systems Device Panel Advisory Committee
  • 19
    • 84855583224 scopus 로고    scopus 로고
    • Transcatheter aortic valve implantation: Assessing the learning curve
    • Alli OO, Booker JD, Lennon RJ, et al Transcatheter aortic valve implantation: assessing the learning curve. JACC. Cardiovasc Interv 2012;5:72-9
    • (2012) JACC. Cardiovasc Interv , vol.5 , pp. 72-79
    • Alli, O.O.1    Booker, J.D.2    Lennon, R.J.3
  • 20
    • 84863337787 scopus 로고    scopus 로고
    • 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement
    • Holmes Jr. DR, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 2012;59:1200-54
    • (2012) J Am Coll Cardiol , vol.59 , pp. 1200-1254
    • Holmes Jr., D.R.1    MacK, M.J.2    Kaul, S.3
  • 21
    • 81255208609 scopus 로고    scopus 로고
    • Rational dispersion for the introduction of transcatheter valve therapy
    • Mack MJ, Holmes Jr DR,. Rational dispersion for the introduction of transcatheter valve therapy. JAMA 2011;306:2149-50
    • (2011) JAMA , vol.306 , pp. 2149-2150
    • MacK, M.J.1    Holmes Jr., D.R.2
  • 22
    • 84884487669 scopus 로고    scopus 로고
    • New data from PARTNER continued access (Non-randomized): Transapical outcomes after TAVR
    • (abstract presentation October 22 2012 (Miami FL))
    • Dewey TM. New data from PARTNER continued access (Non-randomized): transapical outcomes after TAVR. Transcatheter Therapeutics 2012; (abstract presentation, October 22, 2012 (Miami, FL))
    • (2012) Transcatheter Therapeutics
    • Dewey, T.M.1
  • 23
    • 84875737950 scopus 로고    scopus 로고
    • New data from the PARTNER continued access (Non-randomized): Transfemoral outcomes after TAVR
    • (abstract presentation October 22 2012 (Miami FL))
    • Kodali S. New data from the PARTNER continued access (Non-randomized): Transfemoral outcomes after TAVR. Transcatheter Therapeutics 2012; (abstract presentation October 22, 2012 (Miami, FL))
    • (2012) Transcatheter Therapeutics
    • Kodali, S.1
  • 24
    • 84862011069 scopus 로고    scopus 로고
    • Transcatheter Aortic Valve Implantation (TAVI): A health technology assessment update
    • Available at Accessed February 12, 2013
    • Neyt M, Van Brabandt H, Van de Sande S, et al. Transcatheter Aortic Valve Implantation (TAVI): a health technology assessment update. KCE Reports. 2011. p 163. Available at http://www.kce.fgov.be/content/kce-reports. Accessed February 12, 2013
    • (2011) KCE Reports , pp. 163
    • Neyt, M.1    Van Brabandt, H.2    Van De Sande, S.3
  • 25
    • 84871301406 scopus 로고    scopus 로고
    • Cost effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high risk patients with severe aortic stenosis: Results from the PARTNER Trial (Cohort A)
    • Reynolds MR, Magnuson EA, Lei Y, et al. Cost effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high risk patients with severe aortic stenosis: results from the PARTNER Trial (Cohort A). J Am Coll Cardiol 2012;60:2683-92
    • (2012) J Am Coll Cardiol , vol.60 , pp. 2683-2692
    • Reynolds, M.R.1    Magnuson, E.A.2    Lei, Y.3
  • 26
    • 84864774776 scopus 로고    scopus 로고
    • Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: Results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A)
    • Reynolds MR, Magnuson EA, Wang K, et al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol 2012;60:548-58
    • (2012) J Am Coll Cardiol , vol.60 , pp. 548-558
    • Reynolds, M.R.1    Magnuson, E.A.2    Wang, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.